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Using site-directed mutagenesis the single cysteine residue a t  position 24 of 
lactococcin B was replaced by all other possible amino acids. Most of these 
mutant molecules retained bacteriocin activity, with the exception of those in 
which cysteine was replaced by a positively charged amino acid. This would 
seem to be in agreement with the authors' earlier observation that treatment 
of the wild-type molecule with HgCI, resulted in its inactivation. The factor 
that causes inactivation of lactococcin B seems to be the introduction of a 
positive charge at  position 24 by HgCI, rather than oxidation of this residue, as 
treatment of the bacteriocin with other oxidative chemicals did not interfere 
with the ability of lactococcin B to dissipate the membrane potential of 
sensitive cells. Results are also reported which imply that inactive lactococcin B 
can still bind to its receptor. It can be replaced by an active bacteriocin 
molecule, resulting in dissipation of the membrane potential. 
Keywords: lactococcin, secretion, bacteriocin, Lactococcw lactis 
INTRODUCTION 
In the past several years there has been an explosion of 
research activity on bacteriocins produced by lactic acid 
bacteria (Klaenhammer, 1988, 1993 ; Jung & Sahl, 1991 ; 
De Vuyst, 1993; Hoover & Steenson, 1993; Nettles & 
Barefoot, 1993). As this field continues to expand, our 
knowledge about lactic acid bacteria and their bacteriocins 
is increasing rapidly, owing to detailed studies of the 
peptides, their mechanism of action, and the immunity, 
processing and secretion systems involved. Lactococcins 
are bacteriocins produced by Lactococcus lactis. The genes 
specifying production of lactococcins A, B and M, and 
their immunity and secretion are located on plasmid 
p9B4-6 and have been sequenced (Van Belkum e t  al., 
1989, 1991a, 1992). Lactococcins A and B specifically 
inhibit the growth of lactococci, and their modes of action 
have been studied. Both are small cationic, hydrophobic 
peptides that structurally resemble several peptide anti- 
biotics which permeabilize membranes (Kordel & Sahl, 
1986; Kordel e t  al., 1988; Schaller e t  a]., 1989; Galvez e t  
al., 1991 ; Gao e t  al., 1991). At lactococcin concentrations 
that do not affect immune cells, both bacteriocins rapidly 
dissipate the membrane potential of glucose-energized 
sensitive cells of L. lactis and cause efflux of pre- 
accumulated amino acids (Van Belkum e t  al., 1991b; 
Venema e t  al., 1993). Efflux is a direct consequence of 
permeability changes in the cytoplasmic membrane, and is 
not caused by the dissipation of the proton-motive force. 
Both lactococcins are able to permeabilize the cytoplasmic 
membrane in a voltage-independent manner, most likely 
by the formation of pores. It is believed that both 
lactococcins require a proteinaceous receptor for their 
insertion into the cytoplasmic membrane (Van Belkum e t  
al., 1991b; Venema e t  al., 1993, 1994). 
A prerequisite for lactococcin B activity is that its only 
cysteine residue (Cys24) is in the reduced state (Venema e t  
al., 1993). Partially purified (and thus oxidized) lacto- 
coccin B is almost inactive on whole cells. Only after 
addition of dithiothreitol (DTT; 5 mM) is lactococcin B 
capable of dissipating the membrane potential of sensitive 
whole cells. Cys24 in DTT-treated lactococcin B can be 
oxidized by HgCl,, resulting in the inactivation of the 
bacteriocin, while HgC1,-oxidized lactococcin B can be 
reactivated by DTT. It has been postulated that the 
reduced state of the Cys24 residue is required for receptor 
recognition or, alternatively, that the oxidized state of 
Cys24 changes the structure of the molecule in such a way 
that its insertion and/or pore-forming abilities are af- 
fected. In this study we have used site-directed muta- 
genesis together with chemical modification of cys24 to 
investigate these possibilities. 
................................................................................................................................................... ........ 
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METHODS 
Bacterial strains, plasmids and growth conditions. The 
bacterial strains and plasmids used are listed in Table 1. L. lactis 
was cultured in M17 broth (Terzaghi & Sandine, 1975) 
supplemented with 0.5 % glucose (GM17) or in MRS broth (De 
Man e t  al., 1960) containing 0.5 YO glucose. For solid plates, 
1.5 YO (w/v) agar was used. Escbericbia coli was cultured on TY 
medium and plates (Rottlander & Trautner, 1970). Erythro- 
mycin (Em) and chloramphenicol (Cm) were used at final 
concentrations of 5 pg ml-‘ for L. lactis, and 100 pg ml-’ 
and 10 pg ml-’, respectively, for E. coli. 
Molecular cloning, DNA sequencing, and primer synthesis. 
Transformation of L. lactis and E. coli was done as described 
earlier (Venema e t  a/., 1994). General DNA cloning and 
manipulation techniques were used essentially as described by 
Sambrook e t  al. (1989). DNA sequencing was done on double- 
stranded DNA by the dideoxy chain-termination method 
(Sanger e t  al,, 1977), using the T7 sequencing kit and protocol 
(Pharmacia). Synthetic oligodeoxynucleotides were synthesized 
with an Applied Biosystems 381A DNA synthesizer. The 
sequences of the primers were as follows (the position of 
degenerate nucleotides is indicated in parentheses ; the position 
corresponding to that of the cysteine residue is shown in italic; 
the ScaI sites in the primers are underlined): KOVlO: 5’- 
GGTATAAAGATA~TAGTACTGGAAA~AACAATA T- 
( T C A )  TAAACAGACAATTG-3’;KOV11:5’-GGTATAA- 
AGATACTAGTACTGGAAA-AACAATAC(TCAG)(TA) 
AAACAGACAATTG-3’; KOV12: 5’-GGTATAAAGAT 
ACTAGTACTGGAAA-AACAATAA( T C A  G)( TC)AAAC- 
AGACAATTG-3’;  KOV13:  5’ -GGTATAAAGATACT 
AGTACTGGAAA-AACAATAG( TCAG)(  TG)AAACAG 
A C A A T T G - 3 ’ ;  K O V 1 4 :  5 ’ - G G T A T A A A G A T A C T  
AGTACTGGAAA-AACAATA T G G A A A C A G A C A A T  
T G-3’. 
Bacteriocin assay. Overlays on colonies were done as follows : 
colonies were treated with chloroform vapour for 15 min. After 
subsequent exposure of the plates to air for 30 min, M17 soft 
agar (0.75 YO) seeded with 0.1 % of an overnight culture of the 
indicator strain L. lactis IL1403 was poured onto the plates. 
After 12-14 h incubation at 30 OC, the plates were examined for 
Table 7- Bacterial strains and plasmids 
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plasmid 
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Fig. 1. Two-step PCR strategy to change the lcnB codon a t  
position 24. For details of the procedure see Methods. Amp‘, 
ampicillin resistance marker; Ori, origin of replication; uni: 
universal primer; rev, reverse primer; T, position of the 
mutation. 
zones of growth inhibition (haloes). The sizes of the haloes were 
measured from the edge of a bacteriocin-producing colony to 
the edge of the inhibition zone. 
Construction of mutants of lactococcin B. The codon for 
Cys24 in the lactococcin B gene was changed, using a two-step 
PCR strategy, into codons for all other possible amino acids. 
For this, four degenerate primers were used. One primer 
(KOV14) was used to replace Cys24 by tryptophan. The 
lactococcin B operon from pMB580 was cloned in pUC19 as an 
EcoRI-XbaI fragment to give pUC-lcnB. This plasmid was used 
as a template in the first PCR step using the mutation primers 
and the universal primer (Boehringer Mannheim) (Fig. 1). The 
products obtained in the five different reactions were purified by 
Qiaprep PCR columns (Qiagen) and used as primers together 
with the reverse primer (Boehringer) on pUC-lcnB in a second 
PCR step (Fig. 1). The purified PCR products were restricted 
with the enzymes EcoRI and XbaI and cloned in pUC19. The 
ligation mixture was used to transform E.  coli and the 
appropriate constructs were selected by screening for the 
presence of a ScaI site, introduced by the mutation primers. The 
ScaI site does not introduce amino acid change in lactococcin B. 
Inserts containing a ScaI site were sequenced to determine 
which mutation they contained and transferred to pMG36CT 
using the EcoRI and XbaI sites. The set of 19 mutants and the 
wild-type gene, all in pMG36CT, were introduced in L. lactis, 
which was subsequently screened for bacteriocin activity in a 
colony-overlay assay. 
Measurement of cytoplasmic membrane potential. The 
change in cytoplasmic membrane potential of cells of L. lactis 
was monitored by following the distribution of the lipophilic 
cation tetraphenylphosphonium (TPP’) as described previously 
(Venema e t  al., 1993). 
Chemical modification of lactococcin B. Modification of Cys24 
was performed with the following chemicals : cysteine, N- 
ethylmaleimide, p-mercuribenzoate, performic acid, CuSO, and 
HgC1,. Conditions were optimal for reaction of only the thiol 
group with the oxidative chemicals and are described in Means 
& Feeney (1971). The exception was performic acid, which, 
under these conditions, also reacts with methionine. To examine 
Analysis and modification of LcnB 
whether the chemicals had reacted with the cysteine, the 
molecule was subsequently treated with HgCl,, which would 
inactivate the bacteriocin even when it had not reacted with the 
other oxidative chemicals. These data indicated that all the 
chemicals had reacted with Cys24 (data not shown). 
RESULTS 
Cys24 is not essential for lactococcin B activity 
Using a two-step PCR procedure with degenerate primers, 
the gene encoding lactococcin B was mutated in such a 
way that Cys24 was replaced by one of the other 19 amino 
acids. The mutated variants of lcnB together with the 
lactococcin B immunity gene, IciB, were introduced into 
L. Iactir IL1403 and the transformants were tested for 
lactococcin B activity in a colony-overlay assay. As shown 
in Table 2, all mutants produced active bacteriocin, at 
similar levels to the wild-type (data not shown), as judged 
by the presence of a halo around the colonies, with the 
exception of those mutants in which Cys24 had been 
replaced by a positively charged residue : Arg24, His24 or 
Lys24. Apparently, a cysteine residue at position 24 is not 
required for lactococcin B to be active. All active mutants 
displayed a higher bacteriocin activity than the wild-type, 
which can be explained by the fact that in the wild-type 
bacteriocin Cys24 is highly oxidized in the plate assay 
(Venema e t  a/., 1993). All strains were also immune to the 
mutant lactococcin B they produced except for the strain 
producing lactococcin B(Thr24), the colonies of which 
were initially very small. It appeared that the plasmid 
contained one extra mutation: a stop was introduced in 
the fourth codon of the immunity gene by one base 
substitution (data not shown). The number of trans- 
formants obtained with the plasmid carrying the mutated 
immunity gene was the same as that obtained with a 
plasmid carrying a functional immunity gene (data not 
shown). 
Table 2. Activity of lactococcin B variants mutated a t  
residue 24 
..................................................................................................................................................... ..... 
Activity was measured (in triplicate) as a zone of inhibition 
(halo) around a colony producing bacteriocin for 18 h at 30 "C 
using IL1403 as the indicator strain. -, No halo; + , halo 
-6 mm; + +, halo 6-12 mm; + + +, halo 12-18 mm. 
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Fig. 2. Effect of lactococcin B treated with various chemicals on 
the membrane potential of energized cells of L. /actis IL1403. 
All curves have been normalized to that of the positive control, 
addition of valinomycin (h). The chemical bonds formed upon 
oxidation are shown in the boxes. Lactococcin B was treated 
with dithiothreitol (a), HgCI, (b), cysteine (c), N-ethylmaleimide 
(d), p-mercuribenzoate (e), CuSO, (f), and performic acid (9). 
Treated lactococcin B was added when the membrane potential 
had reached i t s  optimum (at the time indicated by the arrow). 
Differences between the final membrane potential of two 
different curves after dissipation with lactococcin B were 
insignificant. 
A chemically introduced positive charge at position 
24 abolishes lactococcin B activity 
Lactococcin B can be inactivated by the oxidation of its 
only cysteine residue by HgC1, (Venema e t  al., 1993). 
Other oxidative chemicals specific for cysteine were tested 
to examine whether the lactococcin B molecule could be 
oxidized and still retain activity. The effect of the oxidized 
bacteriocin on the cytoplasmic membrane potential, as 
measured by the distribution over this membrane of the 
lipophilic cation tetraphenylphosphonium (TPP'), was 
tested. As documented previously, lactococcin B, when 
fully reduced by DTT, dissipates the membrane potential 
of sensitive cells of L. /actis (Fig. 2a). When lactococcin B 
is oxidized by HgCl,, activity is lost completely (Fig. 2b). 
This can be explained by the acquisition of a positive 
charge at  the position of Cys24 [see Fig. 2b, box; chemical 
structures derived from Means & Feeney (1971)] and is in 
agreement with the observation that lactococcin B mu- 
tants, in which Cys24 is replaced by a positively charged 
amino acid, are inactive (see above). To examine whether 
lactococcin B could be oxidized with other chemicals 
2827 
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Fig. 3. Effect of various lactococcin B 
derivatives on the membrane potential of 
energized cells of L. lactis IL1403. All curves 
have been normalized to that of the positive 
control, addition of valinomycin (0. 
Additions (at the time indicated by the 
arrow) were: lactococcin B(Ala24) (a); HgCI,- 
treated lactococcin B(Ala24) (b); HgCI,- 
inactivated lactococcin B (first arrow) 
followed by DlT-treated lactococcin B 
(second arrow) (c); HgCI,-inactivated 
lactococcin B (first arrow) followed by D l T  
(second arrow) (d); HgCI,-inactivated 
lactococcin B (first arrow) followed by 
lactococcin B(Ala24) (second arrow) (e); 
valinomycin as the positive control (0. The 
bars in (c) and (e) indicate the lag time 
between addition of lactococcin B and the 
start of the membrane potential dissipation. 
Differences between the final membrane 
potential of two different curves after 
dissipation with lactococcin B were 
insignificant. 
without introducing a positive charge, the bacteriocin 
was reacted with cysteine, N-ethylmaleimide, p-mercuri- 
benzoate, or CuSO,. As can be seen in Fig. 2(c-f), none of 
these oxidative compounds affected lactococcin B activity. 
The chemical bond that is formed upon oxidation is 
shown in the boxes of these figures. These results indicate 
that it is the presence of a positive charge at this position 
that abolishes bacteriocin activity. Treatment of lacto- 
coccin B with performic acid resulted in loss of activity 
(Fig. 2g), although in this case no positive charge was 
introduced at position 24 (see box in Fig. 2g). Also, the 
lactococcin B molecule containing the Ala24 substitution 
was inactivated by performic acid (data not shown), 
indicating that the inactivation was not caused by 
oxidation of the cysteine residue. 
Lactococcin B(Ala24) dissipates the membrane 
potential of sensitive cells 
The effect of one of the lactococcin B mutants on the 
membrane potential was investigated. The Ala24 mutant 
was chosen, since it produced the largest halo in the 
overlay assay (see Table 2). Fig. 3(a) shows that lacto- 
coccin B(Ala24) dissipated the cytoplasmic membrane 
potential of sensitive cells. As expected, addition of HgC1, 
to lactococcin B(Ala24) had no effect on its activity (Fig. 
3b) since this molecule no longer contains the oxidizable 
cysteine residue. 
HgCI,-inactivated lactococcin B blocks the immediate 
action of subsequently added active lactococcin B 
Approximately 30 s after HgC1,-inactivated lactococcin B 
was added to the cells (Fig. 3c, first arrow), active (DTT- 
treated) lactococcin B was added (Fig. 3c, second arrow). 
Instead of an immediate dissipation of the membrane 
potential, there was a lag of approximately 25 s before 
dissipation started, Moreover, dissipation was much 
slower than when only active (DTT-treated) lactococcin 
B had been added (compare Figs 2a and 3c). T o  exclude 
the possibility that DTT caused this effect it was added to 
cells pretreated with HgC1,-inactivated lactococcin B. As 
can be seen in Fig. 3(d), DTT had no effect on the 
membrane potential of these cells. Apparently, dissipation 
of the membrane potential occurred as the result of the 
addition of the active bacteriocin and not because of re- 
activation of the HgC1,-inactivated molecules. This con- 
clusion is in agreement with the fact that the active Ala24 
mutant is still able to dissipate the membrane potential 
after the lag time of approximately 25 s (Fig. 3e). The 
Arg24 mutant also blocks immediate action of subse- 
quently added lactococcin B (data not shown), similar to 
the effect observed with HgC1,-inactivated lactococcin B. 
DISCUSSION 
The two-step PCR procedure used to construct the 
mutants of lactococcin B produced the correct mutants at 
a frequency of 80%. In the other 20% of cases, extra 
mutations, such as frame-shift mutations and/or nucleo- 
tide substitutions, had been introduced. One example is 
the plasmid encoding lactococcin B(Thr24). In this 
plasmid, a stop was introduced in the fourth codon of the 
immunity gene by one base substitution. The trans- 
formants carrying this plasmid initially grew poorly, but 
their normal growth potential was gradually restored. 
This resumption of growth (tolerance) is frequently 
observed when sensitive cells are exposed to lactococcin 
(Van Belkum e t  al., 199la, 1992) and may be due to a 
change in lipid composition of their membranes (Ming & 
Daeschel, 1995). 
We reported previously that lactococcin B is only active 
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when its single cysteine residue is in the reduced state 
(Venema e t  al., 1993). Here we show that this cysteine can 
be replaced by all other amino acids, except the positively 
charged ones, without losing bacteriocin activity. Also, 
the bacteriocin molecule is still active when oxidized with 
oxidative chemicals other than HgC1, (except performic 
acid). Clearly, Cys24 is not essential for bacteriocin 
activity. In this regard lactococcin B resembles a group of 
thiol-activated toxins in which the reduced state of the 
cysteine residue appears to be essential for the generation 
of functional lesions in toxin-treated membranes, but in 
which the cysteine residue can be replaced with other 
amino acids without loss of activity (Boulnois etal., 1991). 
The fact that Cys24 can even be replaced by proline or 
glycine, two residues able to induce large structural 
changes, probably implies that this part of the molecule is 
not directly involved in the activity mechanism of the 
bacteriocin. 
Addition of active lactococcin B to cells incubated with 
HgC1,-inactivated lactococcin B results in a time lag 
before the onset of dissipation of the membrane potential. 
A possible explanation could be that the inactive bacterio- 
cin is still able to bind to the bacteriocin receptor, and that 
active lactococcin B has to compete with the inactive 
molecules for receptor binding in a time-consuming 
process. Another possibility is that HgC1,-inactivated 
molecules insert into the membrane, but form closed 
pores. Addition of active lactococcin B might then result 
in the formation of mixed pores consisting of both 
inactive and active lactococcin B molecules, which would 
open again when a certain ratio of inactive and active 
molecules is reached. If this interpretation is correct, the 
lag time would represent the time needed to reach the 
critical ratio of active to inactive molecules and would 
agree with the observation that the membrane potential 
dissipated more slowly than when only active lactococcin 
B was added. This might be due to the lower efficiency of 
solute transport through the mixed pores. At present it is 
not possible to distinguish between these two possibilities. 
Resolving this question must await the characterization of 
the lactococcin B receptor. 
Treatment of lactococcin B with performic acid resulted 
in complete loss of bacteriocin activity, most probably 
due to the oxidation of the two methionine residues in the 
lactococcin B molecule, which are oxidized under the 
conditions used (Means & Feeney, 1971). One of the 
methionine residues is present in an amphiphilic helix 
(Met38; Venema, 1995). Oxidation of this residue would 
destroy the amphipathic nature of the helix. Alternatively, 
oxidation of the methionine residue at position 6 of the 
molecule could interfere with activity, for instance by 
blocking receptor binding. 
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